0001799812-21-000002.txt : 20210223 0001799812-21-000002.hdr.sgml : 20210223 20210223162900 ACCESSION NUMBER: 0001799812-21-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 EFFECTIVENESS DATE: 20210223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adjuvant Global Health Technology Fund DE, L.P. CENTRAL INDEX KEY: 0001799812 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-358359 FILM NUMBER: 21665940 BUSINESS ADDRESS: STREET 1: C/O ADJUVANT CAPITAL, L.P. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 917-334-0724 MAIL ADDRESS: STREET 1: C/O ADJUVANT CAPITAL, L.P. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 D/A 1 primary_doc.xml X0708 D/A LIVE 0001799812 Adjuvant Global Health Technology Fund DE, L.P. C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY NEW YORK 10017 917-334-0724 DELAWARE None None Limited Partnership true 2019 GLENN ROCKMAN C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY NEW YORK 10017 Executive Officer JENNY YIP C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY NEW YORK 10017 Executive Officer Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 true 0001799812-20-000002 2019-12-18 true true false 0 48226950 48226950 0 false 14 0 0 0 false Adjuvant Global Health Technology Fund DE, L.P. GLENN ROCKMAN GLENN ROCKMAN SOLE MEMBER OF THE GENERAL PARTNER OF THE GENERAL PARTNER 2021-02-23